earnings digest health care medimmune inc increased sales of flu and child respiratory drugs helped medimmune inc swing to a fourth quarter profit after costs for the acquisition of cellective therapeutics inc weighed down results a year earlier but the gaithersburg md drug makers sales disappointed investors and its shares were down &# or at &# as of p m composite trading on the nasdaq stock market sales of respiratory virus treatment synagis rose though not as much as wall street had expected sales of inhaled influenza vaccine flumist were up sharply in the fourth quarter generating &# million in revenue compared with &# million a year earlier sales of million doses for the flu season still fell short of the companys projections of three million doses 
